Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Barrett Esophagus
Positive safety and efficacy data released for Halo360 system treatment
June 17th, 2005
BARRX Medical, Inc., announced the results of four studies evaluating safety, dosage response, and efficacy of treating Barrett esophagus with the Halo360 system. The study results, presented at Digestive Disease Week, May 14-19, 2005, clearly demonstrate the benefits of the Halo360 system for the treatment of Barrett esophagus, a precancerous condition affecting the lining of the esophagus. Virender K. Sharma, MD, of the Mayo Clinic in Scottsdale, Arizona, presented data from the Ablation of Intestinal Metaplasia (AIM-I) multicenter, prospective, randomized trial of 31 patients examining the safety, feasibility, tolerability, and dose response in...
Source: Drug Week (2005-06-17)
|
